Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 25;7(14):3658-3665.
doi: 10.1182/bloodadvances.2023009707.

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease

Affiliations

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease

Lana Mucalo et al. Blood Adv. .

Abstract

Chronic pain affects 30% to 40% of individuals with sickle cell disease (SCD) and impairs patient functioning. Clinically meaningful, practical, and valid assessment tools for investigation, evaluation, and management of chronic pain are limited, representing a barrier for advancing SCD care. We sought to determine whether patient-reported outcomes (PROs) show preliminary construct validity in identifying individuals with SCD who were a priori defined as suggestive of having chronic pain based on previously published criteria. All individuals completed the Patient-Reported Outcomes Measurement Information System (PROMIS) domains: pain interference, pain behavior, pain quality (nociceptive, neuropathic), fatigue, sleep disturbance, depression, and anxiety; the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) domains: pain impact and emotional impact; and the painDETECT questionnaire. Thirty-three adults living with SCD were enrolled, and 42.4% had chronic pain. Pain-related PROs scores distinctly differentiated individuals with chronic pain from those without. Individuals with chronic pain had significantly worse pain-related PROs scores: PROMIS pain interference (64.2 vs 54.3), PROMIS pain behavior (63.2 vs 50), and ASCQ-Me pain impact (42.9 vs 53.2). According to published PROMIS clinical cut scores for the pain-related domains, individuals with chronic pain were categorized as having moderate impairment, whereas those without chronic pain had mild or no impairment. Individuals with chronic pain had PRO pain features consistent with neuropathic pain and worse scores in fatigue, depression, sleep disturbance, and emotional impact. Pain-related PROs show preliminary construct validity in differentiating individuals with and without chronic SCD pain and could be used as valuable tools for research and clinical monitoring of chronic pain.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: J.S.H. is a consultant for GBT, Forma Therapeutics, and CVS Health. J.J.F. received research funding from Forma, Shire, and Vifor and is on the data and safety monitoring board for Bayer. The remaining authors declare no competing financial interests.

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Severity categorization for PROMIS pain interference and pain behavior scores in individuals with SCD who likely have chronic pain and those who likely do not have chronic pain. Displayed are median T-scores and interquartile ranges of the PROMIS pain interference and pain behavior domains in the chronic pain group and no chronic pain group according to published validated PROMIS score cut points. Data show distinct ranges of scores for both domains without overlap, indicating moderate impairment for those with chronic pain and mild impairment or normal functioning for those without chronic pain.

Similar articles

Cited by

References

    1. van Tuijn CF, van Beers EJ, Schnog JJ, Biemond BJ. Pain rate and social circumstances rather than cumulative organ damage determine the quality of life in adults with sickle cell disease. Am J Hematol. 2010;85(7):532–535. - PMC - PubMed
    1. Panepinto JA, Bonner M. Health-related quality of life in sickle cell disease: past, present, and future. Pediatr Blood Cancer. 2012;59(2):377–385. - PubMed
    1. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease -- life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1644. - PubMed
    1. Shah N, Bhor M, Xie L, Paulose J, Yuce H. Sickle cell disease complications: prevalence and resource utilization. PLoS One. 2019;14(7):e0214355. - PMC - PubMed
    1. Sil S, Cohen LL, Dampier C. Psychosocial and functional outcomes in youth with chronic sickle cell pain. Clin J Pain. 2016;32(6):527–533. - PubMed

Publication types